How a woman’s myomectomy saved her father’s life: evidence of fumarate hydratase–deficient uterine leiomyoma and early detection of germline variants in fumarate hydratase

Objective: To describe a case of a personal and family history of early uterine leiomyomatosis that revealed a pathogenic variant in the FH gene encoding fumarate hydratase. After the patient’s diagnosis, a first-degree relative was detected with early-stage renal cell carcinoma. The patient decided...

Full description

Bibliographic Details
Main Authors: Greysha Rivera-Cruz, M.D., Baris Boyraz, M.D., Ph.D., John C. Petrozza, M.D.
Format: Article
Language:English
Published: Elsevier 2022-03-01
Series:F&S Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2666334121001185
_version_ 1818285219202990080
author Greysha Rivera-Cruz, M.D.
Baris Boyraz, M.D., Ph.D.
John C. Petrozza, M.D.
author_facet Greysha Rivera-Cruz, M.D.
Baris Boyraz, M.D., Ph.D.
John C. Petrozza, M.D.
author_sort Greysha Rivera-Cruz, M.D.
collection DOAJ
description Objective: To describe a case of a personal and family history of early uterine leiomyomatosis that revealed a pathogenic variant in the FH gene encoding fumarate hydratase. After the patient’s diagnosis, a first-degree relative was detected with early-stage renal cell carcinoma. The patient decided to undergo preimplantation genetic testing to reduce the risk to her future children. Design: A case report of autosomal dominant hereditary leiomyomatosis and renal cell cancer syndrome where the patient underwent 2 cycles of in vitro fertilization with preimplantation genetic testing for monogenic disease/aneuploidy (PGT-MA) that resulted in 3 unaffected, euploid embryos. Setting: Large academic single-center hospital. Patient(s): A 35-year-old nulligravida woman with a personal history of an early-onset uterine leiomyomatosis and a family history of renal cell carcinoma and uterine leiomyomas, who is heterozygous for a pathogenic variant in FH and diagnosed with hereditary leiomyomatosis and renal cell cancer syndrome. Informed consent was obtained. Intervention(s): Two laparoscopic myomectomies were performed, and tissue was sent for histopathology and immunostaining. Hereditary leiomyomatosis and renal cell cancer syndrome was confirmed by germline testing, and 2 cycles of PGT-MA were performed. Main Outcome Measure(s): Through PGT-MA, the patient was able to mitigate the risk of passing a known familial variant to her future children. Result(s): After 2 cycles of in vitro fertilization with PGT-MA, 3 unaffected embryos were available for transfer. An unaffected, euploid embryo was transferred for pregnancy, and the patient is currently pregnant in her second trimester. Conclusion(s): Pathogenic variants in FH should be suspected in patients with early-onset uterine leiomyomas and a family history of cutaneous and/or uterine leiomyomas. Familial variant testing is crucial in identifying relatives at risk to start early screening.
first_indexed 2024-12-13T01:05:13Z
format Article
id doaj.art-79c5f3826dc4401593f37a06a9e73cc1
institution Directory Open Access Journal
issn 2666-3341
language English
last_indexed 2024-12-13T01:05:13Z
publishDate 2022-03-01
publisher Elsevier
record_format Article
series F&S Reports
spelling doaj.art-79c5f3826dc4401593f37a06a9e73cc12022-12-22T00:04:34ZengElsevierF&S Reports2666-33412022-03-01312631How a woman’s myomectomy saved her father’s life: evidence of fumarate hydratase–deficient uterine leiomyoma and early detection of germline variants in fumarate hydrataseGreysha Rivera-Cruz, M.D.0Baris Boyraz, M.D., Ph.D.1John C. Petrozza, M.D.2Division of Genetics and Genomics, Harvard Medical School, Boston Children’s Hospital, Boston, Massachusetts; Reprint requests: Greysha Rivera-Cruz, M.D., Division of Genetics and Genomics, Harvard Medical School, Boston Children’s Hospital, 300 Longwood Avenue, Boston, MA 02115.Department of Pathology, Massachusetts General Hospital, Boston, MassachusettsDivision of Reproductive Medicine and In vitro Fertilization, Massachusetts General Fertility Center, Boston, MassachusettsObjective: To describe a case of a personal and family history of early uterine leiomyomatosis that revealed a pathogenic variant in the FH gene encoding fumarate hydratase. After the patient’s diagnosis, a first-degree relative was detected with early-stage renal cell carcinoma. The patient decided to undergo preimplantation genetic testing to reduce the risk to her future children. Design: A case report of autosomal dominant hereditary leiomyomatosis and renal cell cancer syndrome where the patient underwent 2 cycles of in vitro fertilization with preimplantation genetic testing for monogenic disease/aneuploidy (PGT-MA) that resulted in 3 unaffected, euploid embryos. Setting: Large academic single-center hospital. Patient(s): A 35-year-old nulligravida woman with a personal history of an early-onset uterine leiomyomatosis and a family history of renal cell carcinoma and uterine leiomyomas, who is heterozygous for a pathogenic variant in FH and diagnosed with hereditary leiomyomatosis and renal cell cancer syndrome. Informed consent was obtained. Intervention(s): Two laparoscopic myomectomies were performed, and tissue was sent for histopathology and immunostaining. Hereditary leiomyomatosis and renal cell cancer syndrome was confirmed by germline testing, and 2 cycles of PGT-MA were performed. Main Outcome Measure(s): Through PGT-MA, the patient was able to mitigate the risk of passing a known familial variant to her future children. Result(s): After 2 cycles of in vitro fertilization with PGT-MA, 3 unaffected embryos were available for transfer. An unaffected, euploid embryo was transferred for pregnancy, and the patient is currently pregnant in her second trimester. Conclusion(s): Pathogenic variants in FH should be suspected in patients with early-onset uterine leiomyomas and a family history of cutaneous and/or uterine leiomyomas. Familial variant testing is crucial in identifying relatives at risk to start early screening.http://www.sciencedirect.com/science/article/pii/S2666334121001185Fumarate hydrataseuterine leiomyomarenal cell carcinomapreimplantation genetic testing
spellingShingle Greysha Rivera-Cruz, M.D.
Baris Boyraz, M.D., Ph.D.
John C. Petrozza, M.D.
How a woman’s myomectomy saved her father’s life: evidence of fumarate hydratase–deficient uterine leiomyoma and early detection of germline variants in fumarate hydratase
F&S Reports
Fumarate hydratase
uterine leiomyoma
renal cell carcinoma
preimplantation genetic testing
title How a woman’s myomectomy saved her father’s life: evidence of fumarate hydratase–deficient uterine leiomyoma and early detection of germline variants in fumarate hydratase
title_full How a woman’s myomectomy saved her father’s life: evidence of fumarate hydratase–deficient uterine leiomyoma and early detection of germline variants in fumarate hydratase
title_fullStr How a woman’s myomectomy saved her father’s life: evidence of fumarate hydratase–deficient uterine leiomyoma and early detection of germline variants in fumarate hydratase
title_full_unstemmed How a woman’s myomectomy saved her father’s life: evidence of fumarate hydratase–deficient uterine leiomyoma and early detection of germline variants in fumarate hydratase
title_short How a woman’s myomectomy saved her father’s life: evidence of fumarate hydratase–deficient uterine leiomyoma and early detection of germline variants in fumarate hydratase
title_sort how a woman s myomectomy saved her father s life evidence of fumarate hydratase deficient uterine leiomyoma and early detection of germline variants in fumarate hydratase
topic Fumarate hydratase
uterine leiomyoma
renal cell carcinoma
preimplantation genetic testing
url http://www.sciencedirect.com/science/article/pii/S2666334121001185
work_keys_str_mv AT greyshariveracruzmd howawomansmyomectomysavedherfatherslifeevidenceoffumaratehydratasedeficientuterineleiomyomaandearlydetectionofgermlinevariantsinfumaratehydratase
AT barisboyrazmdphd howawomansmyomectomysavedherfatherslifeevidenceoffumaratehydratasedeficientuterineleiomyomaandearlydetectionofgermlinevariantsinfumaratehydratase
AT johncpetrozzamd howawomansmyomectomysavedherfatherslifeevidenceoffumaratehydratasedeficientuterineleiomyomaandearlydetectionofgermlinevariantsinfumaratehydratase